These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17141836)

  • 41. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and external validation of an extended 10-core biopsy nomogram.
    Chun FK; Briganti A; Graefen M; Montorsi F; Porter C; Scattoni V; Gallina A; Walz J; Haese A; Steuber T; Erbersdobler A; Schlomm T; Ahyai SA; Currlin E; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
    Eur Urol; 2007 Aug; 52(2):436-44. PubMed ID: 17010505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.
    Thanigasalam R; Rasiah KK; Stricker PD; Haynes AM; Sutherland SI; Sutherland RL; Henshall SM; Horvath LG
    BJU Int; 2010 Mar; 105(5):642-7. PubMed ID: 19751263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of bladder neck invasion and tumor extension to bladder neck margin by prostatic adenocarcinoma: a nomogram using biopsy data including transition zone tumor morphology.
    Cohen RJ; Li J; Shannon T
    Hum Pathol; 2016 Nov; 57():85-90. PubMed ID: 27473268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation.
    Hansen J; Becker A; Kluth LA; Rink M; Steuber T; Zacharias M; Briganti A; Fisch M; Graefen M; Chun FK
    Urol Oncol; 2015 Sep; 33(9):384.e1-8. PubMed ID: 26122714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting survival of patients with node-positive prostate cancer following multimodal treatment.
    Abdollah F; Karnes RJ; Suardi N; Cozzarini C; Gandaglia G; Fossati N; Bianchi M; Boorjian SA; Sun M; Karakiewicz PI; Montorsi F; Briganti A
    Eur Urol; 2014 Mar; 65(3):554-62. PubMed ID: 24094576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
    Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C
    Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
    Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
    Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of prostate cancer originating from the transition zone.
    King CR; Ferrari M; Brooks JD
    Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.
    Briganti A; Chun FK; Salonia A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
    Eur Urol; 2006 Jun; 49(6):1019-26; discussion 1026-7. PubMed ID: 16530933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
    Richstone L; Bianco FJ; Shah HH; Kattan MW; Eastham JA; Scardino PT; Scherr DS
    BJU Int; 2008 Mar; 101(5):541-6. PubMed ID: 18257855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
    Stephenson AJ; Scardino PT; Eastham JA; Bianco FJ; Dotan ZA; Fearn PA; Kattan MW
    J Natl Cancer Inst; 2006 May; 98(10):715-7. PubMed ID: 16705126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
    Chun FK; Suardi N; Capitanio U; Jeldres C; Ahyai S; Graefen M; Haese A; Steuber T; Erbersdobler A; Montorsi F; Huland H; Karakiewicz PI
    Eur Urol; 2009 Mar; 55(3):617-28-6. PubMed ID: 18499335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
    Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
    Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
    Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
    Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients.
    Beauval JB; Cabarrou B; Gandaglia G; Patard PM; Ouzzane A; de la Taille A; Soulié M; Briganti A; Ploussard G; Rozet F; Roumiguié M
    Prostate; 2017 Jun; 77(8):928-933. PubMed ID: 28370267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.